CURIS, INC. (CRIS) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 13.68M USD | Liabilities, Current |
| Cash and equivalents | 5.07M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $13.68M | $5.07M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $14.97M | $15.00M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $14.08M | $5.06M | (m) | $0.00 | (m) | (m) |
| 2025-09-30 | (m) | $19.91M | $9.05M | (m) | $3.24M | (m) | (m) |
| 2025-06-30 | (m) | $19.37M | $10.14M | (m) | $2.75M | (m) | (m) |
| 2025-03-31 | (m) | $20.12M | $20.28M | (m) | $2.31M | (m) | (m) |
| 2024-12-31 | $23.35M | $19.03M | $20.00M | $0.00 | $3.35M | (m) | 1.23× |
| 2024-09-30 | $23.83M | $22.03M | $20.85M | $0.00 | $2.98M | (m) | 1.08× |
| 2024-06-30 | $30.91M | $19.37M | $10.00M | $18.36M | $2.55M | (m) | 1.60× |
| 2024-03-31 | $42.87M | $11.30M | $29.96M | $10.76M | $2.15M | (m) | 3.79× |
| 2023-12-31 | $59.13M | $13.52M | $26.68M | $29.65M | $2.79M | (m) | 4.37× |
| 2023-09-30 | $71.35M | $13.71M | $24.47M | $44.03M | $2.85M | (m) | 5.20× |
| 2023-06-30 | $65.87M | $9.68M | $19.82M | $43.66M | $2.39M | (m) | 6.80× |
| 2023-03-31 | $74.07M | $8.07M | $31.70M | $40.06M | $2.31M | (m) | 9.18× |
| 2022-12-31 | $88.60M | $10.01M | $19.66M | $65.97M | $2.98M | (m) | 8.85× |
| 2022-09-30 | $101.58M | $13.74M | $29.85M | $68.84M | $2.89M | (m) | 7.39× |
| 2022-06-30 | $109.59M | $12.15M | $34.01M | $73.19M | $2.40M | (m) | 9.02× |
| 2022-03-31 | $122.71M | $9.69M | $18.47M | $102.19M | $2.06M | (m) | 12.66× |
| 2021-12-31 | $119.11M | $13.44M | $40.01M | $75.87M | $3.22M | (m) | 8.86× |
| 2021-09-30 | (m) | $9.47M | $53.02M | (m) | $2.96M | (m) | (m) |
| 2021-06-30 | (m) | $7.87M | $75.03M | (m) | $2.38M | (m) | (m) |
| 2021-03-31 | (m) | $6.99M | $111.03M | (m) | $2.18M | (m) | (m) |
| 2020-12-31 | $171.54M | $10.08M | $129.61M | $38.88M | $3.04M | (m) | 17.02× |
| 2020-09-30 | $26.30M | $9.12M | $23.55M | $0.00 | $2.74M | (m) | 2.88× |
| 2020-06-30 | $26.26M | $9.35M | $23.62M | $153.00K | $2.49M | (m) | 2.81× |
| 2020-03-31 | $15.19M | $5.99M | $12.53M | $153.00K | $2.51M | (m) | 2.54× |
| 2019-12-31 | $23.79M | $6.54M | $15.43M | $5.11M | $3.24M | (m) | 3.64× |
| 2019-09-30 | $30.91M | $4.72M | $21.36M | $6.65M | $2.90M | (m) | 6.55× |
| 2019-06-30 | $37.45M | $4.38M | $27.22M | $8.10M | $2.13M | (m) | 8.55× |
| 2019-03-31 | $44.58M | $4.63M | $42.77M | $30.00K | $1.79M | (m) | 9.63× |
| 2018-12-31 | $27.13M | $13.25M | $23.64M | $634.00K | $2.86M | (m) | 2.05× |
| 2018-09-30 | $33.69M | $13.23M | $25.56M | $5.27M | $2.85M | (m) | 2.55× |
| 2018-06-30 | $42.92M | $14.50M | $30.46M | $9.96M | $2.50M | (m) | 2.96× |
| 2018-03-31 | $50.94M | $14.39M | $24.74M | $23.72M | $2.49M | (m) | 3.54× |
| 2017-12-31 | $63.30M | $14.10M | $38.29M | $21.94M | $3.07M | (m) | 4.49× |
| 2017-09-30 | $71.69M | $14.16M | $49.84M | $19.39M | $2.46M | (m) | 5.06× |
| 2017-06-30 | $53.27M | $14.61M | $26.68M | $24.36M | $2.23M | (m) | 3.65× |
| 2017-03-31 | $63.00M | $10.98M | $42.42M | $18.39M | $2.19M | (m) | 5.74× |
| 2016-12-31 | $46.94M | $13.55M | $26.04M | $18.45M | $2.46M | (m) | 3.47× |
| 2016-09-30 | $55.21M | $12.48M | $20.67M | $32.68M | $1.86M | (m) | 4.42× |
| 2016-06-30 | $63.54M | $11.32M | $8.64M | $53.03M | $1.87M | (m) | 5.62× |
| 2016-03-31 | $74.87M | $11.94M | $14.69M | $58.43M | $1.75M | (m) | 6.27× |
| 2015-12-31 | $84.30M | $10.76M | $33.09M | $49.10M | $2.11M | (m) | 7.84× |
| 2015-09-30 | $95.79M | $9.30M | $28.66M | $64.81M | $2.32M | (m) | 10.30× |
| 2015-06-30 | $101.28M | $9.05M | $31.49M | $67.70M | $2.09M | (m) | 11.19× |
| 2015-03-31 | $101.73M | $9.73M | $23.47M | $76.49M | $1.77M | (m) | 10.45× |
| 2014-12-31 | $51.71M | $10.07M | $7.75M | $42.00M | $1.96M | (m) | 5.14× |
| 2014-09-30 | $56.44M | $9.83M | $7.93M | $46.67M | $1.84M | (m) | 5.74× |
| 2014-06-30 | $60.61M | $9.93M | $10.16M | $45.61M | $4.84M | (m) | 6.11× |
| 2014-03-31 | $59.13M | $7.81M | $7.91M | $49.86M | $1.37M | (m) | 7.57× |
| 2013-12-31 | $59.66M | $6.56M | $9.59M | $48.59M | $1.48M | (m) | 9.10× |
| 2013-09-30 | $64.37M | $5.72M | $13.78M | $49.44M | $1.16M | (m) | 11.26× |
| 2013-06-30 | $58.00M | $5.37M | $9.74M | $47.39M | $863.19K | (m) | 10.81× |
| 2013-03-31 | $51.27M | $3.63M | $9.72M | $40.78M | $764.43K | (m) | 14.11× |
| 2012-12-31 | $56.45M | $3.98M | $12.75M | $42.79M | $908.06K | (m) | 14.19× |
| 2012-09-30 | (m) | $3.98M | $7.81M | (m) | $548.39K | (m) | (m) |
| 2012-06-30 | $45.02M | $3.49M | $12.09M | $32.62M | $318.31K | (m) | 12.89× |
| 2012-03-31 | $45.38M | $3.77M | $14.69M | $30.35M | $339.80K | (m) | 12.04× |
| 2011-12-31 | $37.76M | $3.79M | $15.12M | $22.60M | $42.07K | (m) | 9.97× |
| 2011-09-30 | $28.50M | $3.48M | $11.88M | $16.47M | $137.31K | (m) | 8.19× |
| 2011-06-30 | $32.83M | $3.39M | $6.79M | $25.93M | $99.52K | (m) | 9.69× |
| 2011-03-31 | (m) | (m) | $11.12M | (m) | (m) | (m) | (m) |
| 2010-12-31 | $40.47M | $3.48M | $7.83M | $32.55M | $92.37K | (m) | 11.64× |
| 2010-09-30 | (m) | (m) | $11.61M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $10.91M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $7.28M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $10.16M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |